Labcorp to buy BioReference Health assets for $722 million upfront
Start here
Labcorp has agreed to acquire assets of BioReference Health in a deal structured around $722 million in upfront cash. The acquisition adds BioReference Health's laboratory and diagnostics assets to Labcorp's existing testing business. The transaction was announced as an upfront cash payment, with the possibility of additional financial terms beyond the initial payment not detailed in the announcement. The deal reflects continued consolidation in the clinical diagnostics sector. Closing of the transaction and integration of the acquired assets remain ahead.
Written by a model from the reports · updated 3 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- Google NewsPickLabcorp pays $722M in upfront cash deal for BioReference Health assets - Fierce Biotech
Labcorp is acquiring BioReference Health assets in a deal with $722 million in upfront cash.
Coverage and heat for this story
Reports so far 1·Heat now 4·Peak heat 10 (Oct 18 21:00)·Reports, 24h 0
Two panels, same clock (pointer stays in sync): top is cumulative editorial reports — only rises; last point = All reports; slope = new reports that hour. Bottom is Live-board heatIndex — 7-day participants with a 24-hour half-life, so it can fall when talk cools.